OncoMatch/Clinical Trials/NCT07832617
Protoacoustic Imaging For 3D Mapping
Official title: Protoacoustic Imaging for 3D Mapping the Bragg Peak in Real Time During Proton Therapy (PROTEUS)
Is NCT07832617 recruiting? Yes, currently enrolling (Oct 2026). Studying Radiacoustic Imaging w/Ultrasound. for proton therapy.
Treatment: Radiacoustic Imaging w/Ultrasound. — The purpose of this study is to test a new imaging technology called radioacoustic imaging (RAI) that may help doctors see where radiation is being delivered during proton therapy. During proton therapy, the radiation treatment produces very small sound signals inside the body. This study will use special ultrasound sensors placed on the outside of the body to detect these signals. The information collected may allow researchers to create a picture showing where the radiation dose is being delivered in the body and how much radiation is reaching the treatment area. The goal is to determine whether this technology can safely and accurately measure radiation during proton therapy without requiring any additional procedures or radiation exposure.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Hepatocellular Carcinoma
Prostate Cancer
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- OU Health Stephenson Cancer Center · Oklahoma City, Oklahoma
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07832617 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify